Irritable Bowel Syndrome (IBS) Treatment Global Market Opportunities And Strategies To 2034

Name: Irritable Bowel Syndrome (IBS) Treatment Global Market Opportunities And Strategies To 2034
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Download Sample Buy Report

Irritable Bowel Syndrome (IBS) Treatment Market 2025 – By Treatment Type (Irritable Bowel Syndrome – Constipation-Predominant, Irritable Bowel Syndrome – Diarrhea-Predominant, Probiotic Drugs, Other Treatment Type), By indication (IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-Users (Hospitals, Clinics, Homecare), And By Region, Opportunities And Strategies – Global Forecast To 2035

Irritable Bowel Syndrome (IBS) Treatment Global Market Opportunities And Strategies To 2034

Report Price : $4490.00 | Pages : 366 | Published : October 2025 | Delivery Time: Immediately | Format :

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Regional Data

Irritable Bowel syndrome (IBS) Treatment Market Definition

Irritable bowel syndrome (IBS) treatment involves a combination of medical, dietary, and lifestyle strategies aimed at managing the chronic gastrointestinal symptoms associated with IBS, such as abdominal pain, bloating, diarrhea, and constipation. The primary purpose of IBS treatment is to reduce symptom severity, improve quality of life, and restore normal bowel function. It may include dietary modifications, stress management, and medications.

The irritable bowel syndrome (IBS) treatment market consists of sales by entities (organizations, sole traders and partnerships) of irritable bowel syndrome (IBS) treatment aim to alleviate symptoms and improve patients’ quality of life. IBS treatments are naturally prescribed based on the predominant symptom subtype and are often used in combination with lifestyle modifications, such as diet changes, stress reduction and physical activity.

Irritable Bowel Syndrome (IBS) Treatment Global Market Opportunities And Strategies To 2034 Market Size and growth rate 2025 to 2029: Graph

Irritable Bowel syndrome (IBS) Treatment Market Size

The global irritable bowel syndrome (IBS) treatment market reached a value of nearly $6,877.81 million in 2024, having grown at a compound annual growth rate (CAGR) of 8.49% since 2019. The market is expected to grow from $6,877.81 million in 2024 to $9,888.27 million in 2029 at a rate of 7.53%. The market is then expected to grow at a CAGR of 7.28% from 2029 and reach $14,048.56 million in 2034.

Growth in the historic period resulted from rise in the prevalence of irritable bowel syndrome (IBS), growth in preventive healthcare, changing dietary patterns and rising personalized medicine and targeted therapies. Factors that negatively affected growth in the historic period were side effects of IBS medications and regulatory hurdles.

Going forward, increasing aging population, increased R&D investments on gut health, growing demand for probiotics and growing adoption of non-pharmacological therapies will drive growth. Factors that could hinder the growth of the irritable bowel syndrome (IBS) treatment market in the future include stigma and lack of awareness high cost of newer therapies and impact of trade war and tariff.

Irritable Bowel syndrome (IBS) Treatment Market Drivers

The key drivers of the irritable bowel syndrome (IBS) treatment market include:

Increasing Aging Population

During the forecast period, the increasing aging population is expected to propel the growth of the irritable bowel syndrome (IBS) treatment market. As older adults are more susceptible to gastrointestinal disorders due to age-related changes in gut motility, microbiota composition and immune function. This demographic also experiences a higher burden of chronic conditions, such as diabetes and Parkinson’s disease, which can aggravate IBS symptoms. As elderly individuals are more proactive in seeking healthcare, they contribute to higher diagnosis rates and sustained demand for treatment. Moreover, the need for safe and tolerable long-term therapies in this age group encourages the development of age-appropriate drug formulations. Pharmaceutical companies are increasingly targeting geriatric patients with specialized solutions. Together, these factors expand the market potential within the aging population segment. The increasing aging population during the forecast period in 2024 is 1.20%.

Irritable Bowel syndrome (IBS) Treatment Market Restraints

The key restraints on the irritable bowel syndrome (IBS) treatment market include:

Stigma And Lack Of Awareness

The stigma and lack of awareness is expected to restrict the growth of the irritable bowel syndrome (IBS) treatment market, during the forecast period. Stigma surrounding bowel-related symptoms often prevents individuals from openly discussing their condition or seeking medical help, leading to underdiagnosis and delayed treatment. Many people normalize symptoms like bloating, abdominal pain, or irregular bowel movements, attributing them to lifestyle or diet rather than recognizing them as signs of IBS. This lack of awareness reduces early intervention and limits the demand for specialized treatments. In many regions, especially in low- and middle-income countries, public education about IBS remains minimal, further compounding the issue. Even among healthcare providers, inconsistent diagnostic approaches can lead to misdiagnosis or ineffective treatment. As a result, fewer patients enter the formal treatment pipeline, slowing the overall expansion of the IBS treatment market. Growth affected by stigma and lack of awareness during the forecast period in 2024 is -2.00%.

Irritable Bowel syndrome (IBS) Treatment Market Trends

Major trends shaping the irritable bowel syndrome (IBS) treatment market include:

Focus On Launch Of Microbiome-Based IBS Therapies

Major companies operating in the irritable bowel syndrome (IBS) treatment market are focusing on microbiome-targeted oral therapies such as EBX-102-02, to gain competitive advantage in the market. EBX-102-02 is a next-generation full-spectrum microbiome drug designed to rebalance gut flora and relieve IBS-C symptoms. For example, in March 2025, EnteroBiotix, a US-based clinical-stage biopharmaceutical company, introduced EBX-102-02 in phase 2a trials showing clinically meaningful improvements across multiple symptom domains in IBS-C patients, including IBS-Symptom Severity Scale (IBS-SSS), abdominal pain and stool consistency. This therapy offers target microbiome modulation with oral dosing and favorable tolerability, but outcomes remain preliminary and require larger, longer trials for broader confirmation.

Increasing Collaborations to Develop Innovative IBS Treatments

Companies in the irritable bowel syndrome (IBS) treatment market are focusing on growing number of partnerships between biopharmaceutical and healthcare companies aimed at advancing new and effective treatment options for irritable bowel syndrome (IBS). Such collaborations combine scientific expertise, innovative technologies, and distribution capabilities to bring safer, well-tolerated, and evidence-based therapies to patients. For example, in March 2025, Immuron Limited, an Australia-based biopharmaceutical company, partnered with Calmino Group AB, a Sweden-based science-driven innovative healthcare company, to jointly develop and commercialize a treatment for irritable bowel syndrome (IBS) in the Australia and New Zealand markets. Immuron will exclusively distribute Calmino’s product ProIBS, a certified medical device designed to alleviate symptoms related to IBS such as abdominal pain, bloating, diarrhea and constipation. ProIBS contains AVH200, derived from Aloe barbadensis Miller, which has gel-forming components that support the intestinal mucosal barrier. This collaboration is intended to improve IBS management and expand Immuron’s product offerings with a scientifically supported, safe and well-tolerated option for patients with IBS symptoms.

Opportunities And Recommendations In The Irritable Bowel syndrome (IBS) Treatment Market

Opportunities – The top opportunities in the irritable bowel syndrome (IBS) treatment market segmented by treatment type will arise in the irritable bowel syndrome – diarrhea-predominant segment, which will gain $1,183.50 million of global annual sales by 2029. The top opportunities in the irritable bowel syndrome (IBS) treatment market segmented by indication will arise in the IBS with diarrhea segment, which will gain $1,327.97 million of global annual sales by 2029. The top opportunities in the irritable bowel syndrome (IBS) treatment market segmented by distribution channel will arise in the online pharmacies segment, which will gain $1,580.11 million of global annual sales by 2029. The top opportunities in the irritable bowel syndrome (IBS) treatment market segmented by end-users will arise in the hospitals segment, which will gain $1,318.75 million of global annual sales by 2029. The irritable bowel syndrome (IBS) treatment market size will gain the most in the USA at $917.30 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the irritable bowel syndrome (IBS) treatment companies to focus on advancing microbiome-based oral therapies with clinical validation, focus on personalized nutrition therapies for IBS, focus on expanding digital therapeutics for IBS management, focus on diarrhea-predominant IBS treatments, focus on IBS with constipation segment for growth, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, continue to use B2B promotions, focus on strategic partnerships to expand IBS treatment options, focus on online pharmacies to capture growth in the IBS treatment market and focus on homecare settings to drive growth.

Book your 30 minutes free consultation with our research experts

Irritable Bowel syndrome (IBS) Treatment Market Segmentation

The irritable bowel syndrome (IBS) treatment market is segmented by treatment type, by indication, by distribution and by end-users.

By Treatment Type –

The irritable bowel syndrome (IBS) treatment market is segmented by treatment type into:

a) Into Irritable Bowel Syndrome – Constipation-Predominant

b) Irritable Bowel Syndrome – Diarrhea-Predominant

c) Probiotic Drugs

d) Other Treatment Type

The other treatment type market was the largest segment of the irritable bowel syndrome (IBS) treatment market segmented by treatment type, accounting for 32.26% or $2,218.90 million of the total in 2024. Going forward, the irritable bowel syndrome – diarrhea-predominant segment is expected to be the fastest growing segment in the irritable bowel syndrome (IBS) treatment market segmented by treatment type, at a CAGR of 9.14% during 2024-2029.

By Indication –

The irritable bowel syndrome (IBS) treatment market is segmented by indication into:

a) IBS With Constipation

b) IBS With Diarrhea

c) IBS With Alternating Constipation And Diarrhea

The IBS with constipation market was the largest segment of the irritable bowel syndrome (IBS) treatment market segmented by indication, accounting for 33.32% or $2,291.96 million of the total in 2024. Going forward, the IBS with constipation segment is expected to be the fastest growing segment in the irritable bowel syndrome (IBS) treatment market segmented by indication, at a CAGR of 8.02% during 2024-2029.

By Distribution Channel –

The irritable bowel syndrome (IBS) treatment market is segmented by distribution channel into:

a) Hospital Pharmacies

b) Online Pharmacies

c) Retail Pharmacies

The retail pharmacies market was the largest segment of the irritable bowel syndrome (IBS) treatment market segmented by distribution channel, accounting for 36.03% or $2,478.20 million of the total in 2024. Going forward, the online pharmacies segment is expected to be the fastest growing segment in the irritable bowel syndrome (IBS) treatment market segmented by distribution channel, at a CAGR of 11.67% during 2024-2029.

By End-Users –

The irritable bowel syndrome (IBS) treatment market is segmented by end-users into:

a) Hospitals

b) Clinics

c) Homecare Settings

The hospitals market was the largest segment of the irritable bowel syndrome (IBS) treatment market segmented by end-users, accounting for 48.27% or $3,320.26 million of the total in 2024. Going forward, the homecare settings segment is expected to be the fastest growing segment in the irritable bowel syndrome (IBS) treatment market segmented by end-users, at a CAGR of 8.93% during 2024-2029.

By Geography - The irritable bowel syndrome (IBS) treatment market is segmented by geography into:

o Asia Pacific

• China

• India

• Japan

• Australia

• Indonesia

• South Korea

o North America

• USA

• Canada

o South America

• Brazil

o Western Europe

• France

• Germany

• UK

• Italy

• Spain

o Eastern Europe

• Russia

o Middle East

o Africa

North America was the largest region in the irritable bowel syndrome (IBS) treatment market, accounting for 51.74% or $3,558.24 million of the total in 2024. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the irritable bowel syndrome (IBS) treatment market will be Africa and Middle East where growth will be at CAGRs of 13.12% and 11.67% respectively. These will be followed by Asia-Pacific and South America where the markets are expected to grow at CAGRs of 11.03% and 10.31% respectively.

Irritable Bowel syndrome (IBS) Treatment Market Competitive Landscape

Major Competitors are:

AbbVie Inc.

Bausch Health

Astellas Pharma AS

Ironwood Pharmaceuticals Inc.

Takeda Pharmaceutical Inc

Other Competitors Include:

Ardelyx Inc.

Mallinckrodt Pharmaceuticals plc

Alfasigma

Mahana Therapeutics Inc.

Prometheus Laboratories Inc.

AbbVie

Novartis

AstraZeneca

Takeda

Astellas Pharma India Pvt. Ltd.

Dr. Reddy's Laboratories Ltd

Cipla Limited

Abbott Laboratories

Mallinckrodt Pharmaceuticals

Merck Group

Zydus Lifesciences Limited

Eisai Co., Ltd

Ardelyx

Ironwood Pharmaceuticals

Salix Pharmaceuticals

Astellas Pharma Inc.

Synergy Pharmaceuticals Inc.

CinPhloro Pharma LLC

GlaxoSmithKline Plc (GSK)

Takeda Pharmaceutical Company Limited

Novartis AG

Biomerica Inc.

Takeda Pharmaceutical Company

RedHill Biopharma

Ironwood Pharmaceuticals, Inc.

Astellas Pharma, Inc.

Bayer AG

EnteroBiotix

Biocodex

Author: Abdul Wasay

1 Executive Summary

1.1 Irritable Bowel Syndrome (IBS) Treatment – Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition

6.2 Summary

6.3 Irritable Bowel Syndrome (IBS) Treatment Market Definition And Segmentations

6.4 Market Segmentation By Treatment Type

6.4.1 Irritable Bowel Syndrome – Constipation-Predominant

6.4.2 Irritable Bowel Syndrome – Diarrhea-Predominant

6.4.3 Probiotic Drugs

6.4.4 Other Treatment Type

6.5 Market Segmentation By Indication

6.5.1 IBS With Constipation

6.5.2 IBS With Diarrhea

6.5.3 IBS With Alternating Constipation And Diarrhea

6.6 Market Segmentation By Distribution Channel

6.6.1 Hospital Pharmacies

6.6.2 Online Pharmacies

6.6.3 Retail Pharmacies

6.7 Market Segmentation By End-Users

6.7.1 Hospitals

6.7.2 Clinics

6.7.3 Homecare Settings

7 Major Market Trends

7.1 Focus On Launch Of Microbiome-Based IBS Therapies

7.2 Increasing Collaborations to Develop Innovative IBS Treatments

7.3 Personalized Nutrition Approaches Accelerate Innovation

7.4 Digital Therapeutics Transform IBS Management

8 Global Irritable Bowel Syndrome (IBS) Treatment Growth Analysis And Strategic Analysis Framework

8.1 Global Irritable Bowel Syndrome (IBS) Treatment PESTEL Analysis

8.1.1 Political

8.1.2 Economic

8.1.3 Social

8.1.4 Technological

8.1.5 Environmental

8.1.6 Legal

8.2 Analysis Of End User (B2B or B2C)

8.2.1 Hospitals

8.2.2 Clinics

8.2.3 Homecare Settings

8.3 Global Irritable Bowel Syndrome (IBS) Treatment Market Growth Rate Analysis

8.4 Historic Market Growth, 2019 – 2024, Value ($ Million)

8.4.1 Market Drivers 2019 – 2024

8.4.2 Market Restraints 2019 – 2024

8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)

8.6 Forecast Growth Contributors/Factors

8.6.1 Quantitative Growth Contributors

8.6.2 Drivers

8.6.3 Restraints

8.7 Global Irritable Bowel Syndrome (IBS) Treatment Total Addressable Market (TAM)

9 Global Irritable Bowel Syndrome (IBS) Treatment Market Segmentation

9.1 Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.2 Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.3 Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.4 Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.5 Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Irritable Bowel Syndrome – Constipation-Predominant, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.6 Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Irritable Bowel Syndrome – Diarrhea-Predominant, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.7 Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Probiotic Drugs, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.8 Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Other Treatment Type, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

10 Irritable Bowel Syndrome (IBS) Treatment Market, Regional and Country Analysis

10.1 Global Irritable Bowel Syndrome (IBS) Treatment Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

10.2 Global Irritable Bowel Syndrome (IBS) Treatment Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary

11.2 Market Overview

11.2.1 Region Information

11.2.2 Market Information

11.2.3 Background Information

11.2.4 Government Initiatives

11.2.5 Regulations

11.2.6 Regulatory Bodies

11.2.7 Major Associations

11.2.8 Taxes Levied

11.2.9 Corporate Tax Structure

11.2.10 Investments

11.2.11 Major Companies

11.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.5 Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.6 Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market: Country Analysis

11.7 China Market

11.8 Summary

11.9 Market Overview

11.9.1 Country Information

11.9.2 Market Information

11.9.3 Background Information

11.9.4 Government Initiatives

11.9.5 Regulations

11.9.6 Regulatory Bodies

11.9.7 Major Associations

11.9.8 Taxes Levied

11.9.9 Corporate Tax Structure

11.9.10 Major Companies

11.10 China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.11 China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.12 China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.13 India Market

11.14 India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.15 India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.16 India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.17 Japan Market

11.18 Summary

11.19 Market Overview

11.19.1 Country Information

11.19.2 Market Information

11.19.3 Background Information

11.19.4 Government Initiatives

11.19.5 Regulations

11.19.6 Regulatory Bodies

11.19.7 Major Associations

11.19.8 Taxes Levied

11.19.9 Corporate Tax Structure

11.19.10 Major Companies

11.20 Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.21 Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.22 Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.23 South Korea Market

11.24 Summary

11.25 Market Overview

11.25.1 Country Information

11.25.2 Market Information

11.25.3 Background Information

11.25.4 Government Initiatives

11.25.5 Regulations

11.25.6 Regulatory Bodies

11.25.7 Major Associations

11.25.8 Taxes Levied

11.25.9 Corporate Tax Structure

11.25.10 Major Companies

11.26 South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.27 South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.28 South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.29 Australia Market

11.30 Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.31 Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.32 Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.33 Indonesia Market

11.34 Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.35 Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.36 Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary

12.2 Market Overview

12.2.1 Region Information

12.2.2 Market Information

12.2.3 Background Information

12.2.4 Government Initiatives

12.2.5 Regulations

12.2.6 Regulatory Bodies

12.2.7 Major Associations

12.2.8 Taxes Levied

12.2.9 Corporate tax structure

12.2.10 Investments

12.2.11 Major Companies

12.3 Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.4 Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.5 Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.6 Western Europe Irritable Bowel Syndrome (IBS) Treatment Market: Country Analysis

12.7 UK Market

12.8 UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.9 UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.10 UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.11 Germany Market

12.12 Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.13 Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.14 Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.15 France Market

12.16 France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.17 France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.18 France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.19 Italy Market

12.20 Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.21 Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.22 Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.23 Spain Market

12.24 Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.25 Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.26 Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary

13.2 Market Overview

13.2.1 Region Information

13.2.2 Market Information

13.2.3 Background Information

13.2.4 Government Initiatives

13.2.5 Regulations

13.2.6 Regulatory Bodies

13.2.7 Major Associations

13.2.8 Taxes Levied

13.2.9 Corporate Tax Structure

13.2.10 Investments

13.2.11 Major Companies

13.3 Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.4 Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.5 Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.6 Russia Market

13.7 Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.8 Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.9 Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary

14.2 Market Overview

14.2.1 Region Information

14.2.2 Market Information

14.2.3 Background Information

14.2.4 Government Initiatives

14.2.5 Regulations

14.2.6 Regulatory Bodies

14.2.7 Major Associations

14.2.8 Taxes Levied

14.2.9 Corporate Tax Structure

14.2.10 Investments

14.2.11 Major Companies

14.3 North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.4 North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.5 North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.6 North America Irritable Bowel Syndrome (IBS) Treatment Market: Country Analysis

14.7 USA Market

14.8 Summary

14.9 Market Overview

14.9.1 Country Information

14.9.2 Market Information

14.9.3 Background Information

14.9.4 Government Initiatives

14.9.5 Regulations

14.9.6 Regulatory Bodies

14.9.7 Major Associations

14.9.8 Taxes Levied

14.9.9 Corporate Tax Structure

14.9.10 Investments

14.9.11 Major Companies

14.10 USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.11 USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.12 USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.13 Canada Market

14.14 Summary

14.15 Market Overview

14.15.1 Country Information

14.15.2 Market Information

14.15.3 Background Information

14.15.4 Government Initiatives

14.15.5 Regulations

14.15.6 Regulatory Bodies

14.15.7 Major Associations

14.15.8 Taxes Levied

14.15.9 Corporate Tax Structure

14.15.10 Investments

14.15.11 Major Companies

14.16 Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.17 Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.18 Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary

15.2 Market Overview

15.2.1 Region Information

15.2.2 Market Information

15.2.3 Background Information

15.2.4 Government Initiatives

15.2.5 Regulations

15.2.6 Regulatory Bodies

15.2.7 Major Associations

15.2.8 Taxes Levied

15.2.9 Corporate Tax Structure

15.2.10 Major Companies

15.3 South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.4 South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.5 South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.6 Brazil Market

15.7 Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.8 Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.9 Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary

16.2 Market Overview

16.2.1 Region Information

16.2.2 Market Information

16.2.3 Background Information

16.2.4 Government Initiatives

16.2.5 Regulations

16.2.6 Regulatory Bodies

16.2.7 Major Associations

16.2.8 Taxes Levied

16.2.9 Corporate Tax Structure

16.2.10 Major Companies

16.3 Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

16.4 Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

16.5 Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary

17.2 Market Overview

17.2.1 Region Information

17.2.2 Market Information

17.2.3 Background Information

17.2.4 Government Initiatives

17.2.5 Regulations

17.2.6 Regulatory Bodies

17.2.7 Major Associations

17.2.8 Taxes Levied

17.2.9 Corporate Tax Structure

17.2.10 Major Companies

17.3 Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

17.4 Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

17.5 Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles

18.2 Abbvie Inc.

18.2.1 Company Overview

18.2.2 Products And Services

18.2.3 Financial Overview

18.3 Bausch Health Companies Inc

18.3.1 Company Overview

18.3.2 Products And Services

18.3.3 Business Strategy

18.3.4 Financial Overview

18.4 Astellas Pharma AS

18.4.1 Company Overview

18.4.2 Products And Services

18.4.3 Financial Overview

18.5 Ironwood Pharmaceuticals Inc

18.5.1 Company Overview

18.5.2 Products And Services

18.5.3 Financial Overview

18.6 Takeda Pharmaceutical Company Limited

18.6.1 Company Overview

18.6.2 Products And Services

18.6.3 Financial Overview

19 Other Major And Innovative Companies

19.1 Ardelyx Inc.

19.1.1 Company overview

19.1.2 Products And Services

19.2 Mallinckrodt Pharmaceuticals plc

19.2.1 Company overview

19.2.2 Products And Services

19.3 Alfasigma

19.3.1 Company overview

19.3.2 Products And Services

19.4 Mahana Therapeutics Inc.

19.4.1 Company overview

19.4.2 Products And Services

19.5 Prometheus Laboratories Inc.

19.5.1 Company overview

19.5.2 Products And Services

19.6 Cosmo Technologies Ltd.

19.6.1 Company overview

19.6.2 Products And Services

19.7 Lexicon Pharmaceuticals Inc.

19.7.1 Company overview

19.7.2 Products And Services

19.8 4D Pharma plc (now known as 4D Pharma)

19.8.1 Company overview

19.8.2 Products And Services

19.9 OrphoMed

19.9.1 Company overview

19.9.2 Products And Services

19.10 Boston Pharmaceuticals

19.10.1 Company overview

19.10.2 Products And Services

19.11 Napo Pharmaceuticals (Acquired by Allergan in 2017)

19.11.1 Company overview

19.11.2 Products And Services

19.12 Arena Pharmaceuticals

19.12.1 Company overview

19.12.2 Products And Services

19.13 Tryp Therapeutics

19.13.1 Company overview

19.13.2 Products And Services

19.14 CinRx Pharma

19.14.1 Company overview

19.14.2 Products And Services

19.15 Theriva Biologics Inc. (formerly Synthetic Biologics, Inc.)

19.15.1 Company overview

19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Nerva Acquired Mahana Therapeutics

22.2 Bayer Acquired HiDoc Technologies GmbH

22.3 Roche Acquired Telavant Holdings

23 Recent Developments In Irritable Bowel Syndrome (IBS) Treatment

23.1 Development Of Pediatric Neuromodulation For IBS-Related Pain

23.2 Use Of Targeted Medical Devices

24 Opportunities And Strategies

24.1 Global Irritable Bowel Syndrome (IBS) Treatment Market In 2029 – Countries Offering Most New Opportunities

24.2 Global Irritable Bowel Syndrome (IBS) Treatment Market In 2029 – Segments Offering Most New Opportunities

24.3 Global Irritable Bowel Syndrome (IBS) Treatment Market In 2029 – Growth Strategies

24.3.1 Market Trend Based Strategies

24.3.2 Competitor Strategies

25 Irritable Bowel Syndrome (IBS) Treatment Market, Conclusions And Recommendations

25.1 Conclusions

25.2 Recommendations

25.2.1 Product

25.2.2 Place

25.2.3 Price

25.2.4 Promotion

25.2.5 People

26 Appendix

26.1 Geographies Covered

26.2 Market Data Sources

26.3 Research Methodology

26.4 Currencies

26.5 The Business Research Company

26.6 Copyright and Disclaimer

List Of Tables

Table 1: Global Irritable Bowel Syndrome (IBS) Treatment Market, Historic, 2019 – 2024, $ Million

Table 2: Global Irritable Bowel Syndrome (IBS) Treatment Market, Forecast, 2024 – 2029, 2034F, $ Million

Table 3: Global Irritable Bowel Syndrome (IBS) Treatment Market TAM, 2024 And 2034, $ Million

Table 4: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 5: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 6: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 7: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 8: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Irritable Bowel Syndrome – Constipation-Predominant, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 9: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Irritable Bowel Syndrome – Diarrhea-Predominant, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 10: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Probiotic Drugs, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 11: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Other Treatment Type, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 12: Global Irritable Bowel Syndrome (IBS) Treatment Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 13: Global Irritable Bowel Syndrome (IBS) Treatment Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 14: Asia-Pacific GDP Per Capita, By Country, 2019-2024, $

Table 15: Asia-Pacific Population, By Country, 2019-2029, Millions

Table 16: Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 17: Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 18: Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 19: China GDP Per Capita, 2019-2024, $

Table 20: China Population, 2019-2029, Millions

Table 21: China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 22: China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 23: China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 24: India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 25: India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 26: India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 27: Japan GDP Per Capita, 2019-2024, $

Table 28: Japan Population, 2019-2029, Millions

Table 29: Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 30: Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 31: Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 32: South Korea GDP Per Capita, 2019-2024, $

Table 33: South Korea Population, 2019-2029, Millions

Table 34: South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 35: South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 36: South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 37: Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 38: Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 39: Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 40: Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 41: Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 42: Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 43: Western Europe GDP Per Capita, By Country, 2019-2024, $

Table 44: Western Europe Population, By Country, 2019-2029, Millions

Table 45: Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 46: Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 47: Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 48: UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 49: UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 50: UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 51: Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 52: Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 53: Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 54: France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 55: France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 56: France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 57: Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 58: Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 59: Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 60: Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 61: Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 62: Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 63: Eastern Europe GDP Per Capita, By Country, 2019-2024, $

Table 64: Eastern Europe Population, By Country, 2019-2029, Millions

Table 65: Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 66: Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 67: Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 68: Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 69: Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 70: Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 71: North America GDP Per Capita, By Country, 2019-2024, $

Table 72: North America Population, By Country, 2019-2029, Millions

Table 73: North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 74: North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 75: North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 76: USA GDP Per Capita, 2019-2024, $

Table 77: USA Population, 2019-2029, Millions

Table 78: USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 79: USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 80: USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 81: Canada GDP Per Capita, 2019-2024, $

Table 82: Canada Population, 2019-2029, Millions

Table 83: Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 84: Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 85: Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 86: South America GDP Per Capita, By Country, 2019-2024, $

Table 87: South America Population, By Country, 2019-2029, Millions

Table 88: South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 89: South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 90: South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 91: Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 92: Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 93: Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 94: Middle East GDP Per Capita, By Country, 2019-2024, $

Table 95: Middle East Population, By Country, 2019-2029, Millions

Table 96: Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 97: Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 98: Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 99: Africa GDP Per Capita, By Country, 2019-2024, $

Table 100: Africa Population, By Country, 2019-2029, Millions

Table 101: Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 102: Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 103: Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 104: Global Irritable Bowel Syndrome (IBS) Treatment Market, Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 105: Abbvie Inc – Financial Overview, 2020 – 2024, $Billion

Table 106: Bausch Health Companies Inc – Financial Overview, 2020 – 2024, $Billion

Table 107: Astellas Pharma AS – Financial Overview, 2020 – 2024, $Billion

Table 108: Ironwood Pharmaceuticals Inc – Financial Overview, 2020 – 2024, $Billion

Table 109: Takeda Pharmaceutical Company Limited – Financial Overview, 2020 – 2024, $Billion

Table 110: Irritable Bowel Syndrome (IBS) Treatment Market, Competitive Benchmarking (In USD Billions)

Table 111: Irritable Bowel Syndrome (IBS) Treatment Market, Competitive Dashboard

Table 112: Global Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Million), 2024 – 2029, By Country

Table 113: Global Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Million), Segmentation By Treatment Type, 2024 – 2029

Table 114: Global Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Million), Segmentation By Indication, 2024 – 2029

Table 115: Global Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Million), Segmentation By Distribution Channel, 2024 – 2029

Table 116: Global Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Million), Segmentation By End-Users, 2024 – 2029

Table 117: Irritable Bowel Syndrome (IBS) Treatment Market Data Sources

List Of Figures

Figure 1: Global Irritable Bowel Syndrome (IBS) Treatment Market Segmentation By Treatment Type

Figure 2: Global Irritable Bowel Syndrome (IBS) Treatment Market Segmentation By Indication

Figure 3: Global Irritable Bowel Syndrome (IBS) Treatment Market Segmentation By Distribution Channel

Figure 4: Global Irritable Bowel Syndrome (IBS) Treatment Market Segmentation By End-Users

Figure 5: Global Irritable Bowel Syndrome (IBS) Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 6: Global Irritable Bowel Syndrome (IBS) Treatment Market, Historic, 2019 – 2024, $ Million

Figure 7: Global Irritable Bowel Syndrome (IBS) Treatment Market, Forecast, 2024 – 2029, 2034F, $ Million

Figure 8: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 9: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 10: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 11: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 12: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Irritable Bowel Syndrome – Constipation-Predominant, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 13: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Irritable Bowel Syndrome – Diarrhea-Predominant, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 14: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Probiotic Drugs, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 15: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Other Treatment Type, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 16: Global Irritable Bowel Syndrome (IBS) Treatment Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 17: Global Irritable Bowel Syndrome (IBS) Treatment Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 18: Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 19: Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 20: Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 21: China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 22: China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 23: China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 24: India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 25: India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 26: India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 27: Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 28: Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 29: Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 30: South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 31: South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 32: South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 33: Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 34: Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 35: Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 36: Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 37: Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 38: Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 39: Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 40: Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 41: Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 42: UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 43: UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 44: UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 45: Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 46: Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 47: Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 48: France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 49: France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 50: France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 51: Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 52: Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 53: Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 54: Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 55: Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 56: Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 57: Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 58: Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 59: Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 60: Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 61: Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 62: Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 63: North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 64: North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 65: North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 66: USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 67: USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 68: USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 69: Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 70: Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 71: Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 72: South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 73: South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 74: South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 75: Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 76: Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 77: Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 78: Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 79: Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 80: Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 81: Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 82: Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 83: Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 84: Global Irritable Bowel Syndrome (IBS) Treatment, Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 85: Abbvie Inc – Financial Overview, 2020 – 2024, $ Billion

Figure 86: Bausch Health Companies Inc – Financial Overview, 2020 – 2024, $ Billion

Figure 87: Astellas Pharma AS – Financial Overview, 2020 – 2024, $ Billion

Figure 88: Ironwood Pharmaceuticals Inc – Financial Overview, 2020 – 2024, $ Billion

Figure 89: Takeda Pharmaceutical Company Limited – Financial Overview, 2020 – 2024, $ Billion

Figure 90: Geographic Regions Covered

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor,...

View Report

Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By E...

View Report

Dimension Stone Mining Global Market Report 2020 - By Type (Marble, Granite, Limestone, Sandstone)...

View Report

Crushed Stone Mining Global Market Report 2020 - By Type (Limestone Mining, Granite Mining)...

View Report

Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact...

View Report

Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bu...

View Report

Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User ...

View Report

Payer Services Global Market Report 2025 –By Outsourcing Services (Business Process Outsourcing Services, Knowledge Process Outsourcing Services, Information Technology Outsourcing Services), By Application (Revenue Cycl...

View Report

Irritable Bowel Syndrome (IBS) Treatment Global Market Opportunities And Strategies To 2034

Irritable Bowel Syndrome (IBS) Treatment Global Market Opportunities And Strategies To 2034

Market Insights

Related Reports

Irritable Bowel syndrome (IBS) Treatment Market Definition

Irritable Bowel syndrome (IBS) Treatment Market Size

Irritable Bowel syndrome (IBS) Treatment Market Drivers

Irritable Bowel syndrome (IBS) Treatment Market Restraints

Irritable Bowel syndrome (IBS) Treatment Market Trends

Opportunities And Recommendations In The Irritable Bowel syndrome (IBS) Treatment Market

Irritable Bowel syndrome (IBS) Treatment Market Segmentation

Irritable Bowel syndrome (IBS) Treatment Market Competitive Landscape

Major Competitors are:

Other Competitors Include:

Table Of Contents

List Of Tables

List Of Figures

$5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor,...

Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By E...

Dimension Stone Mining Global Market Report 2020 - By Type (Marble, Granite, Limestone, Sandstone)...

Crushed Stone Mining Global Market Report 2020 - By Type (Limestone Mining, Granite Mining)...

Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact...

Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bu...

Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User ...

Payer Services Global Market Report 2025 –By Outsourcing Services (Business Process Outsourcing Services, Knowledge Process Outsourcing Services, Information Technology Outsourcing Services), By Application (Revenue Cycl...

Frequently Asked Questions

Irritable Bowel Syndrome (IBS) Treatment Global Market Opportunities And Strategies To 2034

Irritable Bowel Syndrome (IBS) Treatment Global Market Opportunities And Strategies To 2034

Global Irritable Bowel Syndrome IBS Treatment Market

Market Insights

Related Reports

Irritable Bowel syndrome (IBS) Treatment Market Definition

Irritable Bowel syndrome (IBS) Treatment Market Size

Irritable Bowel syndrome (IBS) Treatment Market Drivers

Irritable Bowel syndrome (IBS) Treatment Market Restraints

Irritable Bowel syndrome (IBS) Treatment Market Trends

Opportunities And Recommendations In The Irritable Bowel syndrome (IBS) Treatment Market

Irritable Bowel syndrome (IBS) Treatment Market Segmentation

Irritable Bowel syndrome (IBS) Treatment Market Competitive Landscape

Major Competitors are:

Other Competitors Include:

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions